Pfizer confirms high efficacy of COVID-19 antiviral pill Pfizer confirms high efficacy of COVID-19 antiviral pill
WEDNESDAY, DECEMBER 15, 2021
The risk of hospitalization or death was reduced by 89 percent compared to placebo in non-hospitalized, high-risk adult patients with COVID-19 treated within three days of symptom onset, said Pfizer.